Prevention & lipids

1. Eur J Prev Cardiol1 Jun 2026

   Sub-Agatston coronary calcification on non-contrast cardiac CT and cardiovascular risk

   Cohort study

2. JAMA Cardiol1 Jun 2026

   US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024

   Cross-sectional study

3. Eur J Prev Cardiol30 May 2026

   Female-specific risk factors for cardiovascular morbidity and mortality in postmenopauseal women: a systematic review and meta-analysis

   Meta-analysis

4. Eur J Prev Cardiol28 May 2026

   Staffing, accepted indications, and dose of Phase II cardiac rehabilitation: country income class and time-based comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s (ICCPR) 2025 Audit Update

   Cross-sectional study

5. J Am Coll Cardiol27 May 2026

   The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC)

   Cohort study

6. Am Heart J26 May 2026

   Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease

   Trial design

7. J Am Coll Cardiol26 May 2026

   Anti-Inflammatory Effects of Oral NLRP3 Inhibition With Ruvonoflast Among Individuals at Elevated Cardiovascular Risk

   Randomised controlled trial

8. Eur Heart J25 May 2026

   Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement

   Guideline or statement

9. Eur Heart J25 May 2026

   Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials

   Meta-analysis

10. J Am Coll Cardiol25 May 2026

    Resistance Training, Aerobic Activity, Television Viewing, and Risk of Major Cardiovascular Events in U.S. Women

    Cohort study

11. Eur Heart J24 May 2026

    Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals

    Cohort study

12. Eur J Prev Cardiol23 May 2026

    A practical guide to target trial emulation: connecting randomized trials and real-world data in cardiovascular research

    Research article

13. Eur J Prev Cardiol22 May 2026

    Efficacy and safety of oral Pcsk9 inhibitors: insights from a meta-analysis of RCTs

    Meta-analysis

14. JACC Adv21 May 2026

    Trends in the Co-Occurrence of Alcohol Use and Cardiovascular Disease Among U.S. Adults, 1999 to 2023

    Cross-sectional study

15. Eur J Prev Cardiol21 May 2026

    Body composition changes in patients on GLP-1 receptor agonists undergoing an intensive cardiac rehabilitation program

    Cohort study

16. Eur J Prev Cardiol19 May 2026

    Fatty acid–binding protein 4 and major adverse cardiovascular events: a dose–response meta-analysis of prospective cohort studies

    Meta-analysis

17. Eur Heart J18 May 2026

    Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry

    Cohort study

18. Circulation15 May 2026

    Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients

    Randomised controlled trial

19. JACC Adv15 May 2026

    Association of Hypertension With Health Care Access and Utilization Following Childbirth: Differences by Race and Ethnicity

    Cross-sectional study

20. Eur J Prev Cardiol15 May 2026

    Efficacy and safety of aspirin for primary prevention in adults with elevated lipoprotein(a) or genetic susceptibility via LPA gene variants: a systematic review and meta-analysis

    Meta-analysis

21. J Am Coll Cardiol13 May 2026

    Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia: A Population-Based Cohort Study

    Meta-analysis

22. Eur J Prev Cardiol12 May 2026

    Plasma soluble TREM-1 and risk of cardiovascular disease in the population. Results from the Paris Prospective Study III and the CoLaus|PsyCoLaus

    Cohort study

23. Eur J Prev Cardiol11 May 2026

    Joint association of sedentary behaviour and physical activity with cardiovascular disease: a systematic review and meta-analysis

    Meta-analysis

24. Eur J Prev Cardiol9 May 2026

    Reassessing alcohol consumption and cardiovascular disease by addressing bias in observational data: results from the multi-ethnic study of atherosclerosis

    Cohort study

25. Eur J Prev Cardiol9 May 2026

    ASCVD risk stratification using apolipoprotein B and the LDL-C to total cholesterol ratio

    Cohort study

26. Eur J Prev Cardiol8 May 2026

    Moving beyond LDL cholesterol: apolipoprotein B and lipoprotein(a) for sex-specific risk assessment of aortic stenosis in the UK Biobank

    Cohort study

27. Am Heart J7 May 2026

    CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics

    Trial design

28. Eur Heart J7 May 2026

    Environmental risk factors and cardiovascular health

    Guideline or statement

29. Eur Heart J6 May 2026

    Ultra-processed foods, lifestyle management, and cardiovascular diseases: A clinical consensus statement of the European Society of Cardiology Council for Cardiology Practice and the European Association of Preventive Cardiology of the European Society of Cardiology

    Guideline or statement

30. Nat Med5 May 2026

    Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

    Diagnostic or prognostic study

31. Eur J Prev Cardiol5 May 2026

    Cardiovascular risk in women with metabolic dysfunction-associated steatotic liver disease across the menopausal transition

    Cohort study

32. JAMA5 May 2026

    Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy

    Research article

33. Eur J Prev Cardiol5 May 2026

    Diagnosing chronotropic incompetence: a scoping review of current approaches and their application in a cardiac rehabilitation cohort

    Cohort study

34. Heart4 May 2026

    Age and sex-specific reference ranges of left ventricular strain rates and cardiovascular outcomes: the Copenhagen City Heart Study

    Secondary analysis

35. Circ Popul Health Outcomes1 May 2026

    Association Between Discrimination in Health Care and ASCVD Among Middle-Aged and Older Adults in the United States

    Cohort study

36. JAMA Cardiol1 May 2026

    Premature Menopause and Lifetime Risk of Coronary Heart Disease

    Cohort study

37. Eur J Prev Cardiol29 Apr 2026

    The impact of lipoprotein(a) on coronary atherosclerotic plaque phenotype in primary prevention

    Cohort study

38. JACC Adv29 Apr 2026

    Breast Artery Calcification for Primary Prevention of Major Adverse Cardiovascular Outcomes in Women

    Cohort study

39. J Am Coll Cardiol29 Apr 2026

    Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions

    Diagnostic or prognostic study

40. Eur Heart J28 Apr 2026

    Multi-modality non-invasive cardiovascular screening and sex-specific outcomes: the Viborg Screening Program

    Cohort study

All 838 Briefs in ExploreShowing Briefs 161–200 of 838, newest first